●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
$BBOT
|
10-Q
Nov 12, 11:52 AM ET
BridgeBio Oncology Therapeutics, Inc. 10-Q
Loading document...
Contents
27
1. Organization
2. Summary of Significant Accounting Policies
3. PIPE Financing and de-SPAC Transaction
4. Fair Value Measurements and Disclosures
5. In-Licensing and Collaboration Agreements
6. Income from Transition Services Agreement
7. Commitments and Contingencies
8. Redeemable Convertible Preferred Stock and Stockholders’ Deficit
9. Leases
10. Stock-Based Compensation
11. Income Taxes
12. Net Loss Per Share Attributable to Common Stockholders
13. Related Party Transactions
14. Subsequent Events
Overview
De-SPAC Transaction
Related Party Transactions
Emerging Growth Company Status
Impact of General Economic Risk Factors on the Operations of BBOT
Basis of Presentation
Components of Results of Operations
Results of Operations
Liquidity, Going Concern, and Capital Resources
Cash Flows
Off-Balance Sheet Arrangements
Critical Accounting Estimates
Recent Accounting Pronouncements